Loading...
•
May 31, 2021
AngioDynamics Q4 2021 Earnings Report
AngioDynamics experienced a strong fourth quarter with significant sales growth and improved gross margin.
Key Takeaways
AngioDynamics reported a strong Q4 2021 with a 31.7% increase in net sales compared to the prior-year quarter. The company's gross margin improved by 330 basis points year over year. The company is now trending close to normalized run rates. The company recorded a net loss of $19.5 million, or a loss per share of $0.51.
Net sales increased by 31.7% compared to the prior-year quarter.
Gross margin increased by 330 basis points year over year.
GAAP loss per share was $0.51, while adjusted earnings per share was $0.00.
Cash and cash equivalents were $48.2 million on May 31, 2021.
Revenue by Geographic Location
Forward Guidance
The Company expects its fiscal year 2022 net sales to be in the range of $305 to $310 million, gross margin to be approximately 55.0% and adjusted earnings per share in the range of $0.00 to $0.05 as the Company continues to invest in new product launches to drive future growth.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...